Healthcare Equipment and Supplies
Company Overview of DJO Global Inc.
DJO Global Inc. engages in the development, manufacture, and distribution of orthopedic devices for orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries globally. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems, compression garments, therapeutic shoes and inserts, electrical stimulators, and physical therapy products; revenue ge...
1430 Decision Street
Vista, CA 92081
Founded in 1978
Key Executives for DJO Global Inc.
Chief Executive Officer, President and Director
Chief Financial Officer and Executive Vice President
Executive Vice President of Global Operations
President of Global Recovery Sciences Business Unit
President of DJO Surgical
Compensation as of Fiscal Year 2014.
DJO Global Inc. Key Developments
DJO Global, Inc. Appoints Jeanine Kestler as Executive Vice President and Chief Human Resources Officer
Apr 9 15
DJO Global Inc. announced the appointment of Jeanine Kestler as the company's new Executive Vice President and Chief Human Resources Officer, effective April 6, 2015. Ms. Kestler joins DJO Global from Thermo Fisher Scientific/Life Technologies, where she most recently served as Vice President, Human Resources, Global Commercial Operations. In this role, she built a people strategy focused on creating a culture of accountability, driving employee engagement, building management capability, and delivering business results.
DJO Surgical Launches the Exprt, a Revolutionary Revision Knee Using 75% Fewer Instruments
Mar 23 15
DJO Global Inc. is launching the new Exprt Precision System for highly proficient revision knee surgeons at this year’s Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS booth #4425) in Las Vegas, NV. In addition, surgeon and patient experiences from the first surgical cases will be presented during an educational symposium. The Exprt System redefines total knee revision arthroplasty, providing advanced technology to experienced revision surgeons that leads to greater value and efficiency in the operating suite. Exprt’s streamlined, compact design reduces turn times, minimizes waste, and has proven implant design technology - all for 40-70% of the cost of comparable knee revision systems. A simple, comprehensive 2-tray system replaces the traditional 8-tray setup used during complex, total knee revisions, dramatically reducing prep time, eliminating unnecessary surgical steps, and allowing the precision skills of revision surgeons to truly hit the mark. DJO Surgical worked closely with a select group of experienced revision surgeons who have collectively performed over 25 successful revisions with the Exprt to date. These early adopters have praised the system for its effectiveness and minimalist sophistication.
DJO Global Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Sales Guidance for Fiscal 2015
Feb 20 15
DJO Global Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. The company achieved net sales for the fourth quarter of 2014 of $327.1 million, reflecting sales per day, constant currency growth of 4.3%, compared with net sales of $313.6 million for the fourth quarter of 2013. Adjusted EBITDA for the fourth quarter of 2014 was $82.0 million, or 25.1% of net sales, reflecting 10.5% growth when compared with Adjusted EBITDA of $74.2 million, or 23.7% of net sales, for the fourth quarter of 2013. For the fourth quarter of 2014, DJOFL reported a net loss attributable to DJOFL of $7.4 million, compared to a net loss of $131.8 million for the fourth quarter of 2013. Income before income taxes was $4,787,000 against $126,148,000 a year ago.
The company achieved net sales of $1,229.2 million for the twelve months ended December 31, 2014, reflecting growth of 4.6% compared to net sales of $1,175.5 million for the twelve months ended December 31, 2013. Net sales for the twelve months of 2014 were unfavorably impacted by changes in foreign currency exchange rates aggregating $3.0 million compared to the rates in effect in the twelve months of 2013. For the twelve months of 2014, the company reported a net loss attributable to DJOFL of $90.5 million, compared to a net loss attributable to DJOFL of $203.5 million for the twelve months of 2013. Adjusted EBITDA for the twelve months of 2014 was $282.3 million, or 23.0% of net sales, compared to Adjusted EBITDA of $264.7 million, or 22.5% of net sales, for the twelve months of 2013, reflecting growth of 6.6%. Income before income taxes was $75,672,000 against $189,446,000 a year ago.
Based on current foreign currency rates, the company expects sales for the full year of 2015 to be negatively impacted by approximately 300bps.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|